Medication Assisted Treatment (MAT)

Network to discuss various topics in MAT application and policy.

Moderators

Brian Morales

U.S. Department of State

Discussions الملفات الصور مقاطع الفيديو روابط الفعاليات مشاركة المعرفة الكل

مصدر: جاكوبوفسكي ، أ. ، سينغ تان ، س. ، توريس لوكهارت ، ك. يفتقر الأطباء السريريون في المستشفى إلى المعرفة والراحة في بدء الأدوية لاضطراب استخدام المواد الأفيونية: فرص للتدريب على الابتكار. مدمن العلوم كلين الممارسة 18 ، 31 (2023). https://doi.org/10.1186/s13722-023-00386-x تجريدي خلفية نادرا ما...

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder opportunities for training innovation_1.pdf

مصدر: أونوها ، إي إن ، ليف ، جي إيه ، شاكمان ، بي آر ، ماكوليستر ، كيه إي ، بولسكي ، دي ، ومورفي ، إس إم (2021). التقييمات الاقتصادية للعلاج الدوائي لاضطراب استخدام المواد الأفيونية: مراجعة منهجية للأدبيات. القيمة في الصحة ، 24 (7) ، 1068-1083. يبرز هناك أدلة جديدة على البوبرينورفين وأدلة معززة على...

انقر هنا → لقراءة النص الكامل

Source: D’Onofrio G, Hawk KF, Perrone J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023;6(3):e236108. doi:10.1001/jamanetworkopen.2023.6108 Discussion This cohort study used data...

Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl.pdf

Source: Day, N., Wass, M. & Smith, K. Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes. Addict Sci Clin Pract 17, 40 (2022). https://doi.org/10.1186/s13722-022-00323-4 Abstract Background Virtually delivered healthcare (telehealth, telemedicine) has the...

Virtual opioid agonist treatment Alberta’s virtual opioid dependency program and outcomes.pdf

Source: Andraka-Christou, B., Page, C., Schoebel, V. et al. Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants. Addict Sci Clin Pract 17, 43 (2022). https://doi.org/10.1186/s13722-022-00321-6 Abstract Background Medications for opioid use disorder...

Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants_0.pdf

Source: Hodgins, D. C., Budd, M., Czukar, G., Dubreucq, S., Jackson, L. A., Rush, B., ... & Cameron Wild, T. (2022). Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice. The Canadian Journal of Psychiatry...

Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs A National Survey of Policy, Attitudes, and Practice_0.pdf

Source: Pasman, E., Kollin, R., Broman, M. et al. Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addict Sci Clin Pract 17, 35 (2022). https://doi.org/10.1186/s13722-022-00316-3 Abstract Background Though methadone has been shown to...

Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities.pdf

Source: National Academies of Sciences, Engineering, and Medicine. 2022. Methadone Treatment for Opioid Use Disorder: Improving Access through Regulatory and Legal Change: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26635. Methadone is a Food and Drug...

Click here → to read the full text

Source: Meyers-Pantele, S.A., Mittal, M.L., Jain, S. et al. The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance. Subst Abuse Treat Prev Policy 17, 39 (2022). https://doi.org/10.1186/s13011-022-00470-6 Abstract...

The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance.pdf

Methadone Then, Methadone Now. This webinar will focus on Methadone Treatment as in a historical background beginning in the mid-1960’s through 2021 and discuss how a Methadone Treatment program in Cincinnati has dealt with the many changes in treatment. It will review the changing of treatment from...

Source: National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. https://doi.org/10.17226/26060. Description Substance use disorder (SUD) and opioid use disorder are...

Link to free text

Source: Ford, B. R., Bart, G., Grahan, B., Shearer, R. D., & Winkelman, T. N. (2020). Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder. Journal of Addiction Medicine. Abstract Objective: To examine...

Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder.pdf

This webinar presents information about implementing MAT in criminal justice settings, provides insight into current MAT programs, and solutions for overcoming barriers. Learn more about SAMHSA's GAINS Center at https://www.samhsa.gov/gains-center

Source: Langabeer, J., Stotts, A. L., Cortez, A., Tortolero, G., & Champagne-Langabeer, T. (2020). Geographic proximity to buprenorphine treatment providers in the US. Drug and alcohol dependence, 108131. Highlights •Access to treatment remains a concern for patients with opioid use disorder....

Geographic proximity to buprenorphine treatment providers in the US.pdf

Marcie A. Massa and Maegan M. Kenney, Shatterproof Ambassadors, present on The Effects of Stigma: Perspectives from Persons with Lived Experience at the NAM Opioid Collaborative's May 2020 Virtual Symposium.

This session explores the issue of opioid use and misuse among older adult populations and discusses ways to assess this issue locally. Tune-in to learn how to develop a logic model and strategies using CADCA’s Seven Strategies for Community Change, as well as getting key stakeholders to engage in...

As the opioid epidemic continues to cause suffering for millions of Americans, the United States government is responding in many different ways. In 2016, lawmakers passed the Comprehensive Addiction and Recovery Act, which included several grant programs to help reduce opioid-related harm and...

Read the full text here

This animation provides information on how to recognize (signs and symptoms) and respond (to include checking for responsiveness, calling 911, administering naloxone, providing rescue breathing or CPR, and providing aftercare) to a suspected opioid overdose emergency. For more information, please...

Upcoming Events

There aren't any upcoming events

All Events

Medication Assisted Treatment (MAT)

يفتقر الأطباء السريريون في المستشفى إلى المعرفة والراحة في بدء الأدوية لاضطراب استخدام المواد الأفيونية: فرص للتدريب على الابتكار

التقييمات الاقتصادية للعلاج الدوائي لاضطراب استخدام المواد الأفيونية: مراجعة منهجية للأدبيات

Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants

Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice

Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities

Methadone Treatment for Opioid Use Disorder Improving Access through Regulatory and Legal Change: Proceedings of a Workshop

The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance

Methadone Then, Methadone Now, An IntNSA, PCSS Joint Hosted Webinar

Progress of Four Programs from the Comprehensive Addiction and Recovery Act (2021)

Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder

MAT for Opioid Use Disorder in Correctional Settings

Geographic proximity to buprenorphine treatment providers in the U.S.

NAM Opioid Collaborative 5.21 Virtual Symposium - Keynote Presentations

Webinar "Planning Comprehensive Strategies to Address Opioid Misuse Among Older Adults"

Measuring Success in Substance Use Grant Programs Outcomes and Metrics for Improvement

Recognizing and Responding to an Opioid Overdose Emergency

Upcoming Events